Coronavirus infects another Bulacan mayor, 5th since 2020 | Inquirer News

Coronavirus infects another Bulacan mayor, 5th since 2020

By: - Correspondent / @inquirerdotnet
/ 06:10 PM March 17, 2021

SAN ILDEFONSO, Bulacan–Mayor Carla Galvez-Tan on Wednesday (March 17) announced that she had tested positive for SARS Cov2, the virus that causes COVID-19.

Tan immediately suspended afternoon work at the municipal hall following the release of results of her coronavirus tests around 4 a.m.

In her Facebook account, Tan said the municipal hall would be on a two-day lockdown to give way to disinfection.

Article continues after this advertisement

She asked offices in the town hall to operate with a skeletal workforce starting Monday next week (March 22) to render uninterrupted services.

FEATURED STORIES

The mayor said she got herself tested after experiencing body pain, sore throat and difficulty in breathing, which are some of the symptoms of coronavirus infection.

She was the fifth Bulacan mayor to be infected with the virus since 2020.

Edited by TSB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Bulacan, COVID-19, Health, infection, mayor, pandemic, Regions

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.